Collectively, these findings demonstrate that prodrug H62 overcomes melanoma resistance to DHODH inhibition by simultaneously inducing pyroptosis and recruiting NK cells, thereby amplifying pyroptotic cell death through integrated STING activation and targeted DHODH inhibition (Fig. 3P). This evidence concerns the gene DHODH and melanoma.